Vandetanib plus chemotherapy for induction followed by vandetanib or placebo as maintenance for patients with advanced non-small-cell lung cancer: A randomized phase 2 PrECOG study (PrE0501)

Joseph Aisner, Judith B. Manola, Shaker R. Dakhil, Philip J. Stella, Mika A. Sovak, Joan H. Schiller